These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36449030)

  • 1. Modeling study of long-term stability of the monoclonal antibody infliximab and biosimilars using liquid-chromatography-tandem mass spectrometry and size-exclusion chromatography-multi-angle light scattering.
    Legrand P; Dufaÿ S; Mignet N; Houzé P; Gahoual R
    Anal Bioanal Chem; 2023 Jan; 415(1):179-192. PubMed ID: 36449030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-translational modifications comparative identification and kinetic study of infliximab innovator and biosimilars in serum using capillary electrophoresis-tandem mass spectrometry.
    Reinert T; Houzé P; Mignet N; Francois YN; Gahoual R
    J Pharm Biomed Anal; 2023 Sep; 234():115541. PubMed ID: 37399702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA).
    Hermosilla J; Sánchez-Martín R; Pérez-Robles R; Salmerón-García A; Casares S; Cabeza J; Cuadros-Rodríguez L; Navas N
    BioDrugs; 2019 Apr; 33(2):193-205. PubMed ID: 30875076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural identification and absolute quantification of monoclonal antibodies in suspected counterfeits using capillary electrophoresis and liquid chromatography-tandem mass spectrometry.
    Legrand P; Dembele O; Alamil H; Lamoureux C; Mignet N; Houzé P; Gahoual R
    Anal Bioanal Chem; 2022 Mar; 414(8):2699-2712. PubMed ID: 35099584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of middle- and bottom-up mass spectrometry in forced degradation studies of bevacizumab and infliximab.
    Dyck YFK; Rehm D; Winkler K; Sandig V; Jabs W; Parr MK
    J Pharm Biomed Anal; 2023 Oct; 235():115596. PubMed ID: 37540995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of originator and biosimilar therapeutic monoclonal antibodies using comprehensive two-dimensional liquid chromatography coupled with time-of-flight mass spectrometry.
    Sorensen M; Harmes DC; Stoll DR; Staples GO; Fekete S; Guillarme D; Beck A
    MAbs; 2016 Oct; 8(7):1224-1234. PubMed ID: 27362833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies.
    Xie H; Chakraborty A; Ahn J; Yu YQ; Dakshinamoorthy DP; Gilar M; Chen W; Skilton SJ; Mazzeo JR
    MAbs; 2010; 2(4):379-94. PubMed ID: 20458189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry.
    Gahoual R; Biacchi M; Chicher J; Kuhn L; Hammann P; Beck A; Leize-Wagner E; François YN
    MAbs; 2014; 6(6):1464-73. PubMed ID: 25484058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and characterization of antibody variants using mass spectrometry-based comparative analysis for biosimilar candidates of monoclonal antibody drugs.
    Li W; Yang B; Zhou D; Xu J; Ke Z; Suen WC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1025():57-67. PubMed ID: 27214604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis.
    D'Atri V; Fekete S; Beck A; Lauber M; Guillarme D
    Anal Chem; 2017 Feb; 89(3):2086-2092. PubMed ID: 28208257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multidimensional Analytical Comparison of Remicade and the Biosimilar Remsima.
    Pisupati K; Tian Y; Okbazghi S; Benet A; Ackermann R; Ford M; Saveliev S; Hosfield CM; Urh M; Carlson E; Becker C; Tolbert TJ; Schwendeman SP; Ruotolo BT; Schwendeman A
    Anal Chem; 2017 May; 89(9):4838-4846. PubMed ID: 28365979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications.
    Duivelshof BL; Jiskoot W; Beck A; Veuthey JL; Guillarme D; D'Atri V
    Anal Chim Acta; 2019 Dec; 1089():1-18. PubMed ID: 31627805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of infliximab solutions in different temperature and dilution conditions.
    Tokhadze N; Chennell P; Le Basle Y; Sautou V
    J Pharm Biomed Anal; 2018 Feb; 150():386-395. PubMed ID: 29287266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS Characterization and Stability Assessment Elucidate Correlation Between Charge Variant Composition and Degradation of Monoclonal Antibody Therapeutics.
    Malani H; Shrivastava A; Nupur N; Rathore AS
    AAPS J; 2024 Apr; 26(3):42. PubMed ID: 38570351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™.
    Pisupati K; Benet A; Tian Y; Okbazghi S; Kang J; Ford M; Saveliev S; Sen KI; Carlson E; Tolbert TJ; Ruotolo BT; Schwendeman SP; Schwendeman A
    MAbs; 2017 Oct; 9(7):1197-1209. PubMed ID: 28787231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupling Multi-Angle Light Scattering to Reverse-Phase Ultra-High-Pressure Chromatography (RP-UPLC-MALS) for the characterization monoclonal antibodies.
    Gentiluomo L; Schneider V; Roessner D; Frieß W
    Sci Rep; 2019 Oct; 9(1):14965. PubMed ID: 31628369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Comparative Signature Diagrams to Evaluate Similarity of Storage Stability Profiles of Different IgG1 mAbs.
    Kim JH; Joshi SB; Esfandiary R; Iyer V; Bishop SM; Volkin DB; Middaugh CR
    J Pharm Sci; 2016 Mar; 105(3):1028-35. PubMed ID: 26886311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.
    Wooding KM; Peng W; Mechref Y
    Curr Pharm Biotechnol; 2016; 17(9):788-801. PubMed ID: 27033511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiattribute Monitoring of Aggregates and Charge Variants of Monoclonal Antibody through Native 2D-SEC-MS-WCX-MS.
    Kumar S; Savane TS; Rathore AS
    J Am Soc Mass Spectrom; 2023 Jul; 34(7):1263-1271. PubMed ID: 37327380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous quantification and structural characterization of monoclonal antibodies after administration using capillary zone electrophoresis-tandem mass spectrometry.
    Reinert T; Gahoual R; Mignet N; Kulus A; Allez M; Houzé P; François YN
    J Pharm Biomed Anal; 2023 Sep; 233():115446. PubMed ID: 37209497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.